Increasing evidence suggests that H19 is abnormally expressed in breast, liver, lung, cervical, esophageal, and bladder tumors [27, 28], and promotes cancer cell proliferation, suggesting an oncogenic function. This evidence concerns the gene H19 and urinary bladder neoplasm.